CINECA IRIS Institutional Research Information System

PAPOTTI, Mauro Giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.727
EU - Europa 18.574
AS - Asia 12.978
SA - Sud America 1.549
OC - Oceania 308
AF - Africa 269
Continente sconosciuto - Info sul continente non disponibili 32
Totale 62.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.795
CN - Cina 5.250
IT - Italia 4.480
SG - Singapore 3.335
DE - Germania 2.100
IE - Irlanda 1.865
FR - Francia 1.587
SE - Svezia 1.512
UA - Ucraina 1.269
BR - Brasile 1.122
GB - Regno Unito 1.090
FI - Finlandia 1.077
KR - Corea 964
AT - Austria 697
CA - Canada 690
JP - Giappone 685
IN - India 663
PL - Polonia 628
VN - Vietnam 467
ES - Italia 416
TR - Turchia 382
NL - Olanda 367
HK - Hong Kong 301
AU - Australia 278
DK - Danimarca 220
ID - Indonesia 213
RU - Federazione Russa 207
MX - Messico 206
BE - Belgio 184
GR - Grecia 179
AR - Argentina 156
TW - Taiwan 131
CH - Svizzera 120
RO - Romania 115
PT - Portogallo 106
CO - Colombia 101
SN - Senegal 85
CZ - Repubblica Ceca 77
IL - Israele 64
CL - Cile 59
SA - Arabia Saudita 57
PH - Filippine 56
PK - Pakistan 56
TH - Thailandia 55
MY - Malesia 52
UZ - Uzbekistan 52
HU - Ungheria 51
NO - Norvegia 50
EG - Egitto 45
EC - Ecuador 35
ZA - Sudafrica 32
EU - Europa 31
IR - Iran 31
HR - Croazia 30
NZ - Nuova Zelanda 29
RS - Serbia 29
DZ - Algeria 28
AE - Emirati Arabi Uniti 27
VE - Venezuela 27
PE - Perù 25
SI - Slovenia 25
IQ - Iraq 23
MA - Marocco 18
SK - Slovacchia (Repubblica Slovacca) 17
BG - Bulgaria 14
JO - Giordania 14
LT - Lituania 13
MU - Mauritius 13
TN - Tunisia 12
AM - Armenia 11
BD - Bangladesh 11
NG - Nigeria 11
PY - Paraguay 11
BY - Bielorussia 10
KZ - Kazakistan 10
EE - Estonia 8
MK - Macedonia 8
UY - Uruguay 8
AZ - Azerbaigian 7
GT - Guatemala 7
HN - Honduras 7
OM - Oman 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 5
CY - Cipro 5
GE - Georgia 5
KG - Kirghizistan 5
PR - Porto Rico 5
PS - Palestinian Territory 5
SC - Seychelles 5
SD - Sudan 5
KE - Kenya 4
LB - Libano 4
LK - Sri Lanka 4
LU - Lussemburgo 4
LV - Lettonia 4
NP - Nepal 4
PA - Panama 4
QA - Qatar 4
SY - Repubblica araba siriana 4
Totale 62.388
Salva come PNG Salva come JPEG
Città #
Chandler 2.630
Beijing 2.582
Santa Clara 1.912
Dublin 1.830
Singapore 1.802
Houston 1.751
Fairfield 1.447
Ann Arbor 1.089
Ashburn 1.049
Torino 930
Wilmington 869
Jacksonville 819
Redwood City 800
Villeurbanne 754
Woodbridge 741
Seattle 629
Vienna 602
Medford 597
Princeton 578
Columbus 557
Cambridge 515
Nyköping 515
Warsaw 490
Dearborn 488
Turin 430
Pisa 424
Milan 352
Fremont 327
Boston 288
Shanghai 273
Guangzhou 245
New York 231
Dong Ket 225
Boardman 194
Tokyo 183
Nanjing 181
Toronto 181
Jakarta 179
Hong Kong 170
Munich 169
Hangzhou 148
Verona 146
Rome 145
Düsseldorf 144
Helsinki 140
Hefei 121
Seoul 116
São Paulo 116
Chicago 110
Norwalk 105
Nuremberg 105
Pune 105
San Diego 103
Washington 101
Brussels 96
London 93
Los Angeles 91
Montréal 90
Madrid 86
Chengdu 83
Tappahannock 79
Shenyang 77
Zhengzhou 77
Silver Spring 75
Falls Church 74
Wuhan 74
Bologna 72
Buenos Aires 71
Paris 71
Istanbul 70
Phoenix 69
Würzburg 69
Lachine 67
Ankara 66
Athens 66
Taipei 66
Jinan 64
Ottawa 64
Mcallen 63
Mountain View 62
Kunming 61
Changsha 59
Rochester 57
Pittsburgh 55
Amsterdam 52
Frankfurt am Main 52
Santiago 50
New Delhi 48
Central District 47
Rio de Janeiro 47
Moscow 46
Birmingham 45
Padova 44
Barcelona 43
Dallas 43
Florence 43
Hebei 42
Bethesda 41
Bogotá 41
The Dalles 40
Totale 34.624
Salva come PNG Salva come JPEG
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.405
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.211
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma 1.086
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 906
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 849
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 746
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 716
What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? 604
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 546
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied 496
Eccrine spiradenoma of the nipple: Case report, differential diagnosis and literature review 486
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 467
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 462
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 451
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 448
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 445
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 441
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas 418
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 409
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 409
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 381
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 366
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index - Which is the best predictor of prostate cancer after a negative biopsy? 345
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 344
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 343
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 340
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 340
Detection of EGFR mutations in archival lung cancer samples by pyrosequencing 335
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 333
Mesothelioma families without inheritance of a BAP1 predisposing mutation 325
An international Ki67 reproducibility study in adrenal cortical Carcinoma 324
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations 321
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors 320
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 310
Core biopsies of renal masses: a safe and accurate tool for managing all that is indeterminate 305
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 303
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 303
Updates on lung neuroendocrine neoplasm classification 301
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 292
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 290
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 287
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 283
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 280
Adjuvant mitotane treatment for adrenocortical carcinoma 276
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC. 274
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 270
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 267
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 259
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 258
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 257
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 255
Morgana is a new oncosuppressor in CML 246
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 242
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 239
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 235
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 230
Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy 224
YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study 224
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 222
ELOVL5 Mutations Cause Spinocerebellar Ataxia 38 221
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. 218
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 217
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 217
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 216
Impact of COVID-19 lockdown measures on oncological surgical activity: Analysis of the surgical pathology caseload of a tertiary referral hospital in Northwestern Italy 213
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 213
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 209
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 201
Differentiation-inducing factor 1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and Thymidylate Synthase mRNAs accumulation 200
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 199
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. 198
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines 198
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 198
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 189
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 187
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 186
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 185
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 184
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 184
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 183
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 178
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 175
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 175
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 170
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 169
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 167
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. 165
Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract 165
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 162
Classification of pulmonary neuroendocrine tumors: New insights 160
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. 153
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 152
Current state-of-the-art therapy for advanced squamous cell lung cancer 149
Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal 149
mTOR/p70S6K in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. 147
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 147
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 140
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 139
Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer 138
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target 138
Totale 31.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.820
article - articoli 0
book - libri 0
conference - conferenze 13.364
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.184
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.032 0 0 0 0 0 0 0 0 0 0 615 417
2020/20216.665 578 455 587 389 591 495 602 376 667 623 489 813
2021/20226.619 336 377 372 474 358 349 478 412 287 469 1.334 1.373
2022/20239.107 924 626 227 882 857 2.266 714 576 974 249 460 352
2023/20244.783 588 779 340 276 323 591 208 276 58 278 399 667
2024/202510.535 221 892 470 1.113 2.955 951 471 769 1.581 885 227 0
Totale 64.360